Ankyra Therapeutics
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $60M
Investors
- 7
About Ankyra Therapeutics
Ankyra Therapeutics, Inc., founded in 2019 and headquartered in Boston, US, specializes in anchored-drug conjugates. The company was formed by founders Darrell Irvine and Karl Wittrup.Ankyra Therapeutics is primarily focused on the development of anchored-drug conjugates, specifically utilizing their innovative Anchored Immunotherapy platform to create therapeutics aimed at enhancing anti-tumor responses while ensuring patient safety. Their flagship product, the IL-12 anchored-drug conjugate, has demonstrated therapeutic activity in preclinical models and is currently under evaluation for treating patients with advanced solid tumors.Ankyra Therapeutics operates within a collaboration-driven revenue model, engaging in partnerships with healthcare providers and research institutions focused on oncology.In August 2021, Ankyra Therapeutics, Inc. The company aims to expand its therapeutic offerings and market presence, with specific plans to target additional regions within North America and Europe.
Who invested in Ankyra Therapeutics
7 investors across 2 rounds
See all investors in Ankyra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ankyra Therapeutics
Who invested in Ankyra Therapeutics?
Ankyra Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ankyra Therapeutics raised?
Ankyra Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ankyra Therapeutics last raise money?
Ankyra Therapeutics's most recent round on record is a Series B, in Aug 2021.
What does Ankyra Therapeutics do?
Ankyra Therapeutics is a biotechnology company.
Where is Ankyra Therapeutics headquartered?
Ankyra Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Ankyra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ankyra Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ankyra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.